Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
The report details the trend, potential and market size of Duchenne Muscular Dystrophy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Duchenne Muscular Dystrophymarket, defines the market attractiveness level of Duchenne Muscular Dystrophy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Duchenne Muscular Dystrophy industry, describes the types of Duchenne Muscular Dystrophy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Duchenne Muscular Dystrophy market and the development prospects and opportunities of Duchenne Muscular Dystrophy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Duchenne Muscular Dystrophy market in Chapter 13.
By Player:
Bristol-Myers Squibb
PTC Therapeutics
Others
By Type:
Deflazacort
Prednisone
Others
By End-User:
Male
Female
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Duchenne Muscular Dystrophy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Duchenne Muscular Dystrophy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Duchenne Muscular Dystrophy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Duchenne Muscular Dystrophy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Duchenne Muscular Dystrophy Market Analysis and Outlook to 2022
-
7.1 Global Duchenne Muscular Dystrophy Consumption (2017-2022)
-
7.2 United States Duchenne Muscular Dystrophy Consumption (2017-2022)
-
7.3 Europe Duchenne Muscular Dystrophy Consumption (2017-2022)
-
7.4 China Duchenne Muscular Dystrophy Consumption (2017-2022)
-
7.5 Japan Duchenne Muscular Dystrophy Consumption (2017-2022)
-
7.6 India Duchenne Muscular Dystrophy Consumption (2017-2022)
-
7.7 South Korea Duchenne Muscular Dystrophy Consumption (2017-2022)
8 Region and Country-wise Duchenne Muscular Dystrophy Market Analysis and Outlook to 2028
-
8.1 Global Duchenne Muscular Dystrophy Consumption Forecast (2022-2028)
-
8.2 United States Duchenne Muscular Dystrophy Consumption Forecast (2022-2028)
-
8.3 Europe Duchenne Muscular Dystrophy Consumption Forecast (2022-2028)
-
8.4 China Duchenne Muscular Dystrophy Consumption Forecast (2022-2028)
-
8.5 Japan Duchenne Muscular Dystrophy Consumption Forecast (2022-2028)
-
8.6 India Duchenne Muscular Dystrophy Consumption Forecast (2022-2028)
-
8.7 South Korea Duchenne Muscular Dystrophy Consumption Forecast (2022-2028)
9 Global Duchenne Muscular Dystrophy Market Outlook by Types and Applications to 2022
-
9.1 Global Duchenne Muscular Dystrophy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Deflazacort Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Prednisone Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Duchenne Muscular Dystrophy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Male Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Female Consumption and Growth Rate (2017-2022)
10 Global Duchenne Muscular Dystrophy Market Outlook by Types and Applications to 2028
-
10.1 Global Duchenne Muscular Dystrophy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Deflazacort Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Prednisone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Duchenne Muscular Dystrophy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Male Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Female Consumption Forecast and Growth Rate (2022-2028)
11 Global Duchenne Muscular Dystrophy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Duchenne Muscular Dystrophy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Duchenne Muscular Dystrophy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Duchenne Muscular Dystrophy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Duchenne Muscular Dystrophy Market Competitive Analysis
-
14.1 Bristol-Myers Squibb
-
14.1.1 Bristol-Myers Squibb Company Details
-
14.1.2 Bristol-Myers Squibb Duchenne Muscular Dystrophy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bristol-Myers Squibb Duchenne Muscular Dystrophy Product and Service
-
14.2 PTC Therapeutics
-
14.2.1 PTC Therapeutics Company Details
-
14.2.2 PTC Therapeutics Duchenne Muscular Dystrophy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 PTC Therapeutics Duchenne Muscular Dystrophy Product and Service
-
14.3 Others
-
14.3.1 Others Company Details
-
14.3.2 Others Duchenne Muscular Dystrophy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Others Duchenne Muscular Dystrophy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Duchenne Muscular Dystrophy
-
Figure Duchenne Muscular Dystrophy Picture
-
Table Global Duchenne Muscular Dystrophy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Duchenne Muscular Dystrophy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Duchenne Muscular Dystrophy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Duchenne Muscular Dystrophy Consumption by Country (2017-2022)
-
Figure United States Duchenne Muscular Dystrophy Consumption and Growth Rate (2017-2022)
-
Table Europe Duchenne Muscular Dystrophy Consumption and Growth Rate (2017-2022)
-
Figure China Duchenne Muscular Dystrophy Consumption and Growth Rate (2017-2022)
-
Figure Japan Duchenne Muscular Dystrophy Consumption and Growth Rate (2017-2022)
-
Figure India Duchenne Muscular Dystrophy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Duchenne Muscular Dystrophy Consumption and Growth Rate (2017-2022)
-
Figure Global Duchenne Muscular Dystrophy Consumption Forecast by Country (2022-2028)
-
Figure United States Duchenne Muscular Dystrophy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Duchenne Muscular Dystrophy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Duchenne Muscular Dystrophy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Duchenne Muscular Dystrophy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Duchenne Muscular Dystrophy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Duchenne Muscular Dystrophy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Deflazacort Consumption and Growth Rate (2017-2022)
-
Figure Global Prednisone Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Male Consumption and Growth Rate (2017-2022)
-
Figure Global Female Consumption and Growth Rate (2017-2022)
-
Figure Global Deflazacort Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prednisone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Male Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Female Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Duchenne Muscular Dystrophy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Duchenne Muscular Dystrophy Export by Region (Top 5 Countries) (2017-2028)
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Duchenne Muscular Dystrophy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Duchenne Muscular Dystrophy Product and Service
-
Table PTC Therapeutics (Foundation Year, Company Profile and etc.)
-
Table PTC Therapeutics Duchenne Muscular Dystrophy Sales, Price, Value and Gross Profit (2017-2022)
-
Table PTC Therapeutics Duchenne Muscular Dystrophy Product and Service
-
Table Others (Foundation Year, Company Profile and etc.)
-
Table Others Duchenne Muscular Dystrophy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Others Duchenne Muscular Dystrophy Product and Service
-
